Catalyst Wire Dossier Catalyst Wire Dossier

Atropine 0.1% ophthalmic solution

atropine · Eyenovia Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Atropine 0.1% ophthalmic solution, covering 2025-01-06 to 2025-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression [Phase 3]

See pricing